Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,384 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $473.50 | 8 | $0 (2022) |
| Celgene Corporation | $385.63 | 3 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $204.00 | 2 | $0 (2018) |
| Aurinia Pharma U.S., Inc. | $112.48 | 1 | $0 (2021) |
| AbbVie, Inc. | $100.48 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $50.00 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $41.15 | 1 | $0 (2021) |
| Novo Nordisk Inc | $16.67 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $233.87 | 4 | Amgen Inc. ($183.87) |
| 2021 | $290.64 | 5 | Amgen Inc. ($137.01) |
| 2019 | $260.63 | 2 | Celgene Corporation ($260.63) |
| 2018 | $295.11 | 4 | Celgene Corporation ($125.00) |
| 2017 | $303.66 | 3 | Amgen Inc. ($124.18) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2022 | Amgen Inc. | Enbrel (Biological), Otezla, Prolia | Food and Beverage | In-kind items and services | $67.58 | General |
| Category: Inflammation | ||||||
| 10/21/2022 | Amgen Inc. | AVSOLA (Biological), RIABNI | Food and Beverage | In-kind items and services | $34.42 | General |
| Category: Inflammation | ||||||
| 10/20/2022 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $81.87 | General |
| 09/23/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $112.48 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/20/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $41.15 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2021 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $63.96 | General |
| Category: Inflammation | ||||||
| 09/18/2021 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $51.64 | General |
| Category: Inflammation | ||||||
| 09/17/2021 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Inflammation | ||||||
| 08/15/2019 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $129.46 | General |
| Category: Dermatology | ||||||
| 02/11/2019 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $131.17 | General |
| Category: Dermatology | ||||||
| 10/18/2018 | Celgene Corporation | Otezla (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Dermatology | ||||||
| 04/17/2018 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 04/14/2018 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: Inflammation | ||||||
| 03/01/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Diabetes | ||||||
| 11/06/2017 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $124.18 | General |
| 11/05/2017 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $100.48 | General |
| 11/04/2017 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $79.00 | General |
| Category: DERMATOLOGY | ||||||
About Dr. Lynnette Tatosyan, MD
Dr. Lynnette Tatosyan, MD is a Internal Medicine healthcare provider based in Panorama City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1609924620.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lynnette Tatosyan, MD has received a total of $1,384 in payments from pharmaceutical and medical device companies, with $233.87 received in 2022. These payments were reported across 18 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,384).
Practice Information
- Specialty Internal Medicine
- Location Panorama City, CA
- Active Since 01/08/2007
- Last Updated 12/03/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1609924620
Products in Payments
- Otezla (Drug) $385.63
- Enbrel (Biological) $233.03
- COSENTYX (Biological) $204.00
- LUPKYNIS (Drug) $112.48
- OFEV (Drug) $50.00
- BENLYSTA (Biological) $41.15
- AVSOLA (Biological) $34.42
- Victoza (Drug) $16.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Panorama City
Dr. Shehnaz Habib, M.d, M.D
Internal Medicine — Payments: $9,542
Hermilito Villar
Internal Medicine — Payments: $3,753
Erica Chen, M.d, M.D
Internal Medicine — Payments: $3,561
Dr. Kevin Wu, Md, MD
Internal Medicine — Payments: $3,250
Jacob Schwartz, Pa-C, PA-C
Internal Medicine — Payments: $2,627
Joselito Babaran, Md, MD
Internal Medicine — Payments: $1,850